Nucleus Network Pty Ltd.
Nucleus Network Pty Ltd.
Melbourne, Australia3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-50 Years | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07831226 | |
| Evaluation of the Safety, Tolerability and Pharmacokinetics of HY6725 in Healthy Adult Participants | Healthy | Recruiting | Phase 1 | 2026-03-11 | NCT07262281 | |
| A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Active, not recruiting | Phase 1 | 2025-03-13 | NCT06442241 |